Inventor · disambiguated record
Juan Carlos Almagro
Also filed as: ALMAGRO JUAN C · ALMAGRO JUAN CARLOS
28 granted patents·18 pending applications·177 citations·filing 2006–2024
96Inventor score
Top patents by PatentIndex Score
46 records- 0196US9102737B2Human anti-CD27 antibodies, methods and usesJANSSEN BIOTECH INC·Filed 2013·Granted Aug 11, 2015·36 cites·16 claims
- 0294US8580714B2Methods of affinity maturing antibodiesALMAGRO JUAN CARLOS·Filed 2010·Granted Nov 12, 2013·26 cites·6 claims
- 0391US10239945B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Mar 26, 2019·13 cites·14 claims
- 0490US10844124B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Nov 24, 2020·6 cites·13 claims
- 0590US9683046B2Nucleic acid molecules encoding anti-CD27 antibodiesJANSSEN BIOTECH INC·Filed 2015·Granted Jun 20, 2017·7 cites·20 claims
- 0690US8519107B2IL-17A antibodiesALMAGRO JUAN CARLOS·Filed 2010·Granted Aug 27, 2013·24 cites·16 claims
- 0789US8951525B2Human tissue factor antibody and uses thereofJANSSEN BIOTECH INC·Filed 2013·Granted Feb 10, 2015·11 cites·17 claims
- 0889US8722044B2Human tissue factor antibody and uses thereofALMAGRO JUAN CARLOS·Filed 2012·Granted May 13, 2014·12 cites·19 claims
- 0988US8999333B2Human tissue factor antibody and uses thereofJANSSEN BIOTECH INC·Filed 2014·Granted Apr 7, 2015·9 cites·15 claims
- 1087US8399630B2Engineered anti-IL-13 antibodies, compositions, methods and usesSWANSON RONALD V·Filed 2009·Granted Mar 19, 2013·11 cites·5 claims
- 1185US2024141055A1Human Anti-CD27 AntibodiesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1284US12043670B2Anti-BCMA antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2021·Granted Jul 23, 2024·1 cites·48 claims
- 1384US10301392B2Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodiesJANSSEN BIOTECH INC·Filed 2017·Granted May 28, 2019·3 cites·5 claims
- 1483US8323646B2Engineered anti-IL-13 antibodies, compositions, methods and usesSWANSON RONALD V·Filed 2009·Granted Dec 4, 2012·7 cites·3 claims
- 1581US10829553B2Interferon beta antibodies and uses thereofPFIZER·Filed 2017·Granted Nov 10, 2020·2 cites·17 claims
- 1678US12448439B2Interferon beta antibodies and uses thereofPFIZER·Filed 2023·Granted Oct 21, 2025·0 cites·9 claims
- 1778US8785605B2Humanized IL-25 antibodiesALMAGRO JUAN CARLOS·Filed 2011·Granted Jul 22, 2014·5 cites·13 claims
- 1876US9163083B2Human oncostatin M antibodiesJANSSEN BIOTECH INC·Filed 2013·Granted Oct 20, 2015·2 cites·24 claims
- 1975US2025059293A1Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2024·Application pending·0 cites
- 2073US11732050B2Neutralizing human anti-CD27 antibodiesJANSSEN BIOTECH INC·Filed 2020·Granted Aug 22, 2023·0 cites·7 claims
- 2173US2024352143A1Anti-cd73 antibodies and uses thereofINCYTE CORP·Filed 2024·Application pending·0 cites
- 2272US10941197B2Method of treating osteoarthritis with human oncostatin M antibodiesJANSSEN BIOTECH INC·Filed 2018·Granted Mar 9, 2021·0 cites·5 claims
- 2372US2024327535A1Anti-bcma antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 2469US10689453B2Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodiesJANSSEN BIOTECH INC·Filed 2019·Granted Jun 23, 2020·0 cites·5 claims
- 2567US9062305B2Generation of human de novo pIX phage display librariesTSUI PING·Filed 2009·Granted Jun 23, 2015·2 cites·1 claims
- 2665US12018089B2Anti-CD73 antibodies and uses thereofINCYTE CORP·Filed 2020·Granted Jun 25, 2024·0 cites·27 claims
- 2765US11858986B2Interferon beta antibodies and uses thereofPFIZER·Filed 2020·Granted Jan 2, 2024·0 cites·18 claims
- 2865US2021079091A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 2964US11692035B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Jul 4, 2023·0 cites·17 claims
- 3064US2019112373A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 3164US2021070865A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 3262US12060433B2CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2020·Granted Aug 13, 2024·0 cites·39 claims
- 3361US2021205311A1Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 InhibitorsINCYTE CORP·Filed 2020·Application pending·0 cites
- 3460US2018142019A1Therapeutic cd47 antibodiesTIOMA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3559US10179812B2Method of treating idiopathic pulmonary fibrosis by administering human oncostatin M antibodiesJANSSEN BIOTECH INC·Filed 2017·Granted Jan 15, 2019·0 cites·4 claims
- 3658US2022233529A1Combination therapy comprising a2a/a2b inhibitors, pd-1/pd-l1 inhibitors, and anti-cd73 antibodiesINCYTE CORP·Filed 2021·Application pending·0 cites
- 3757US2022251191A1Therapeutic compositions and methods for treating cancer in combination with analogs of interleukin proteinsARCH ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 3855US9587018B2Polynucleotides encoding human oncostatin M antibodiesJANSSEN BIOTECH INC·Filed 2015·Granted Mar 7, 2017·0 cites·21 claims
- 3954US2022226469A1Therapeutic sirp-alpha antibodiesARCH ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 4053US2022313819A1Combination therapy for the treatment of solid and hematological cancersARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 4153US2012093833A1Human Oncostatin M Antibodies and Methods of UseALMAGRO JUAN CARLOS·Filed 2011·Application pending·0 cites
- 4252US11202828B2Therapeutic SIRP-α antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Dec 21, 2021·0 cites·21 claims
- 4352US2010261620A1Methods of Humanizing and Affinity-Maturing AntibodiesALMAGRO JUAN CARLOS·Filed 2009·Application pending·0 cites
- 4448US2021324075A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 4543US2019309066A1Combination therapy for the treatment of solid and hematological cancersARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 4641US2009155850A1Horse:Human Chimeric AntibodiesFLORIDA INTERNAT UNIVERSITY BO·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →